Urgent Family Care logo
Urgent Family Care
Quality Healthcare
When You Need It Most
(865) 288-7777

Coronavirus (COVID-19) | Medical Study | Association of Race With Mortality Among Patients Hospitalized With Coronavirus Disease 2019 (COVID-19) at 92 US Hospitals

Hassan Nadrous

Study Name:
Association of Race With Mortality Among Patients Hospitalized With Coronavirus Disease 2019 (COVID-19) at 92 US Hospitals

Question:
Is race associated with mortality among patients hospitalized with coronavirus disease 2019 (COVID-19) in the United States?

Findings:
In this cohort study of 11 210 individuals with COVID-19 presenting for care at 92 hospitals across 12 states, there was no difference in all-cause, in-hospital mortality between White and Black patients after adjusting for age, sex, insurance status, comorbidity, neighborhood deprivation, and site of care.

Meaning:
In this study, race was not independently associated with in-hospital mortality after adjusting for differences in sociodemographic and clinical factors.

Source:
JAMA Network | Association of Race With Mortality Among Patients Hospitalized With Coronavirus Disease 2019 (COVID-19) At 92 US Hospitals. 

Related Post

Urgent Family Care blog fallback

COVID-19 | Medical Editorial | Convalescent plasma is ineffective for covid-19

Convalescent plasma generated great enthusiasm in the earliest days of the coronavirus disease 2019 (covid-19) pandemic because of a plausible mechanism of action, its 100 year history of use in the treatment of other infectious diseases, and rapid availability from voluntary donors.
Read This Article
Urgent Family Care blog fallback

COVID-19 | Medical Research Study | Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)

Research Abstract Objective: To investigate the effectiveness of using convalescent plasma to treat moderate coronavirus disease 2019 (covid-19) in adults in India.
Read This Article
Urgent Family Care blog fallback

COVID-19 | Research Study | Remdesivir has little or no impact on survival, W.H.O. trial shows

The largest trial to date of treatments repurposed for use in the covid-19 pandemic has shown that none of the four drugs studied produced any measurable benefit in mortality or disease course. This includes remdesivir—a drug already recommended by several guidelines and pre-ordered by numerous governments around the world.
Read This Article